Ken Griffin Precipio, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.6 - $1.0 $840 - $1,400
-1,400 Reduced 14.43%
8,300 $5,000
Q4 2022

Feb 14, 2023
SELL
$0.5 - $17.4 $3,500 - $121,799
-7,000 Reduced 41.92%
9,700 $5,000
Q3 2022

Nov 14, 2022
SELL
$0.78 - $17.8 $19,734 - $450,340
-25,300 Reduced 60.24%
16,700 $13,000

Others Institutions Holding PRPO

# of Institutions
1
Shares Held
340
Call Options Held
0
Put Options Held
0
View Full List

About Precipio, Inc.

PRPO Quotes by TradingView
  • Ticker PRPO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 22,736,500
  • Market Cap $143M
  • Description
  • Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...
More about PRPO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email